Paperpal Prime Logo

The Lancet Haematology : Impact Factor & More

eISSN: 2352-3026pISSN: 2352-3026

Key Metrics

CiteScore
19.9
SNIP
5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on The Lancet Haematology

The Lancet Haematology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in The Lancet Haematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Haematology

Sex and gender inequality in classical haematology: time to act.
  • 1 Aug 2026
  • The Lancet. Haematology
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial.
  • 1 Aug 2026
  • The Lancet. Haematology
Faggot cells in pericardial fluid.
  • 1 Aug 2026
  • The Lancet. Haematology
Between rules and reality.
  • 1 Aug 2026
  • The Lancet. Haematology
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.
  • 1 Aug 2026
  • The Lancet. Haematology
Expanding access to menstrual health: areas for attention.
  • 1 Aug 2026
  • The Lancet. Haematology
Sex and gender inequality in classical haematology: time to act.
  • 1 Aug 2026
  • The Lancet. Haematology
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial.
  • 1 Aug 2026
  • The Lancet. Haematology
Faggot cells in pericardial fluid.
  • 1 Aug 2026
  • The Lancet. Haematology
Between rules and reality.
  • 1 Aug 2026
  • The Lancet. Haematology
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.
  • 1 Aug 2026
  • The Lancet. Haematology
Expanding access to menstrual health: areas for attention.
  • 1 Aug 2026
  • The Lancet. Haematology

FAQs on The Lancet Haematology